Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Ingevity CorporationNYSE: NGVT

Net Receivables · Q3 FY2026 · quarter ended Sep 2026

Net receivables falls 8.2% from a year ago

Net receivables stood at $154.3M at the end of Q3 FY2026, down 8.2% from a year earlier and down 1.0% from the prior quarter. Over 3 fiscal years it compounded at -14.1% a year.

Context

  • Net receivables amounted to 10.3% of total assets at the end of Q3 FY2026, up 1.1 pp from a year earlier.
  • Net receivables increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps falling in the next quarterly balance sheet after a -8.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$154.3M-1.0% QoQ
Last fiscal yearDec 2025
$157.8M-3.0% YoY
Year agoSep 2025
$168.1M-8.2% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.2%——
1 year-3.0%——
3-year CAGR-14.1%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
157.8M USD
Year-over-year change
-3.0%
4-year CAGR
-4.7%

Net Receivables vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -8.2% is the 9th highest of 11, against a peer median of +6.8%.
  • Net receivables amounts to 10.3% of total assets for NGVT, versus a peer median of 12.3%.
NGVT Competitors
Net Receivables for NGVT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
FMCFMC CorporationMar 2026$2.24B USD-22.6%-12.2%23.8%
OLNOlin CorporationJun 2026$988.6M USD-7.9%-2.0%13.3%
CCThe Chemours CompanyJun 2026$907M USD-5.4%+2.7%12.7%
KWRQuaker Chemical CorporationSep 2026$487.96M USD+11.9%-4.1%16.7%
MTXMinerals Technologies Inc.Apr 2026$412.7M USD+1.7%-0.3%11.9%
IOSPInnospec Inc.Jun 2026$408.6M USD+21.6%+0.8%22.1%
ASHAshland Inc.Jun 2026$256M USD+27.4%-15.6%5.6%
NGVTIngevity CorporationSep 2026$154.3M USD-8.2%-14.1%10.3%
AAUCAllied Gold CorporationJun 2026$102.26M USD+204.5%+25.0%4.6%
ELVRElevra Lithium LimitedJun 2026A$81.48M AUD+145.2%+61.6%6.0%
SKESkeena Resources LimitedSep 2026CA$8.6M CAD-10.5%—0.4%
Peer median (excluding NGVT) —+6.8%-0.3%12.3%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents275.4M76.7M95.9M68M78.1M
Short-term Investments00000
Net Receivables191.4M249.3M211M162.7M157.8M
Inventory241.2M335M308.8M195.9M186M
Other Current Assets7.1M12.5M33.4M58.8M23.6M
Total Current Assets724.9M683.3M658.6M493.2M454.2M
Property, Plant & Equipment (Net)772.1M855.2M829.3M687.6M637.6M
Goodwill442M518.5M527.5M175.2M4.3M
Intangible Assets378.7M455.8M385.3M323.9M215.5M
Long-term Investments35.3M109.8M99.2M87.3M83.1M
Tax Assets6.8M5.7M11.6M117.9M117M
Other Non-current Assets109.2M108.2M111.8M137.5M139.4M
Total Non-current Assets1.74B2.05B1.96B1.53B1.2B
Total Assets2.47B2.74B2.62B2.02B1.65B
Account Payables125.8M174.8M158.4M94.5M92M
Short-term Debt19.6M900K84.4M61.3M47.1M
Tax Payables14.4M8.9M16.7M5.6M0
Deferred Revenue00000
Other Current Liabilities1.1M6.9M15.1M500K14.7M
Total Current Liabilities268.9M303.5M362.9M264.1M341.3M
Long-term Debt1.25B1.47B1.38B1.24B1.06B
Deferred Tax Liabilities114.6M106.5M70.9M56.2M57.3M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities125.5M114.9M126.7M130.6M39M
Total Non-current Liabilities1.53B1.73B1.63B1.56B1.28B
Total Liabilities1.8B2.04B1.99B1.83B1.62B
Common Stock400K400K400K400K400K
Retained Earnings796.1M1.01B1B572M404.9M
Accumulated OCI13.1M(46.8M)(26.7M)(41.4M)500K
Other Stockholders Equity00000
Minority Interest00000
Total Equity673.8M698.3M631.4M195.2M29.7M
Total Debt1.32B1.53B1.53B1.45B1.24B
Net Debt1.05B1.45B1.44B1.39B1.16B

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.